Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Viaplay announces first winners of Viaplay Original Talent Awards

· ‘No Angel’, ‘Crowded’ and ‘One of the Boys’ enter development as Viaplay Originals · Viaplay Original Talent Awards support new creators across Scandinavia · Promoting Nordic storytelling a key sustainability priority for Viaplay Viaplay has announced the three winners of its first Viaplay Original Talent Awards, a pan-Scandinavian initiative to support new creators and promote local storytelling. Following a competitive pitching process, three diverse and innovative projects will enter development as Viaplay Originals – satirical horror ‘No Angel’, black comedy ‘Crowded’ and

Camurus Annual Report for 2021

Lund, Sweden — 6 April 2021 — Camurus (CAMX) today announces that the Annual Report for 2021 now is available at the company’s website: www.camurus.com, and as an attachment to this press release. The Swedish version of the Annual Report is also available on the website in European Single Electronic Format (ESEF). “2021 was a productive and successful year for Camurus where we, under challenging market conditions, continued to advance our business towards our strategic goals. Revenues grew by high double digits and the operating result continued to improve whilst we made significant

AFRYs Annual and Sustainability Report for 2021 is now published

AFRY AB has today published the Annual and Sustainability Report for 2021 and it is available on the company website afry.com.The Report presents the company’s business strategy with a strong focus on sustainability and digitalisation. We also report the company's taxonomy-eligible turnover of 48 percent and our new climate roadmap, AFRY 1.5⁰C Roadmap, which describes our climate action. “2021 was another eventful year for AFRY, characterized by continued increased demand for sustainable and digital solutions, especially in our industrial segments. Organic growth was strong, results were

Basis swap and AT1 impact in Q1 2022

In the first quarter of 2022, the DNB Group will recognise a positive effect of NOK 629 million from basis swaps connected to funding. Furthermore, a negative effect of NOK 138 million from the USD Additional Tier 1 capital will also be recognised. For further information, please contact: Rune Helland, head of Investor Relations, tel. (+47) 23 26 84 00 / (+47) 977 13 250 This information is subject to the disclosure requirements according to Section 5-12 of the Norwegian Securities Trading Act.

Eficode wins Atlassian Partner of the Year award 2021 in Services, EMEA

Eficode earns the Atlassian Partner award now for the eight timeHelsinki, April 6, 2022 - Atlassian today named Eficode, the company creating the future of software development in Europe, the Atlassian Partner of the Year 2021: Services, EMEA.  In 2021, Eficode  continued to grow Atlassian services’  adoption, both in managed services , and through professional services. In 2021, customers running

Read original

Invitation to AAK’s presentation of the first quarter 2022 on April 27

In connection with the release of AAK’s Interim report for the first quarter 2022, we invite you to a press and analyst conference to be held on Wednesday, April 27, 2022, at 1 p.m. CET. The conference will be chaired by Johan Westman, President and CEO, and Tomas Bergendahl, CFO. The presentation will be held in English. The presentation can be followed by phone or via a webcast. Please note that questions may be asked by phone only. To follow the conference by phone, please use one of the following numbers:SE: +46 8 566 427 06DK: +45 7872 3250UK: +44 3333 009 271US: +1 646

BioStock Studio: Elicera’s immuno-oncology platform iTANK reaches high-impact journal

Gothenburg-based gene therapy company Elicera Therapeutics recently announced the publication of a scientific article describing the mechanism-of-action of its universal CAR T-cell enhancement technology platform iTANK. The publication came in Nature Biomedical Engineering, one of the highest ranked scientific journals in the world. CSO and co-founder Professor Magnus Essand joined BioStock Studio via link from Uppsala to tell us more about iTANK and the importance of this publication.Watch the full interview with Elicera's CSO and Co-founder Magnus Essand at biostock.se: https://www.

Apetit's Säkylä frozen foods plant's energy solution will be renewed – new energy solutions will reduce the plant's CO2 emissions by 80 per cent

Apetit Plc, press release, 6 April 2022 at 10:30 a.m.Apetit's Säkylä frozen foods plant's energy solution will be renewed – new energy solutions will reduce the plant's CO2 emissions by 80 per cent The energy solution of Apetit's Säkylä frozen foods plant will be completely renewed. The new energy solution will increase the share of renewable energy used at the plant to about 70 per cent and significantly improve energy efficiency through heat recovery. Previously, Säkylä's energy solution has been based on fossil fuels. “The new solution develops the operations of the factory in two

ZINZINO AB (PUBL): Zinzino acquires brand portfolio with Swiss skincare and supplements

Zinzino, the global health and wellness brand from Scandinavia, has acquired the Swiss companies Enhanzz Global AG and Enhanzz IP AG, including their skincare brand HANZZ+HEIDII and multifunctional nutrition label YU. This is a strategic and important step in Zinzino’s growth plans, with a focus on enhancing personal health and wellness on a global level with cutting-edge biotechnology and a groundbreaking product portfolio distributed through direct sales.Enhanzz is an innovative direct sales company from Switzerland specializing in exclusive, natural and vegan skincare products. The

Resolutions of Etteplan Oyj’s Annual General Meeting of Shareholders

ETTEPLAN OYJ, Stock Exchange Release, April 6, 2022 at 10.30 Resolutions of Etteplan Oyj’s Annual General Meeting of Shareholders The Annual General Meeting of Etteplan Oyj (the “Company”) was held today, April 6, 2022, at Leonardo auditorium, Innopoli 1, Espoo, Finland. The Annual General Meeting approved the financial statements and discharged the members of the Board of Directors and the President and CEO from liability for the financial year 2021. The Annual General Meeting resolved, in accordance with the proposal of the Board of Directors, to pay a dividend of EUR 0.40 per

Risk Intelligence A/S signs agreement for LandRisk Logistics with Monitoring Services ESOES

Risk Intelligence A/S (“Risk Intelligence” or "the Company") announces today that it has signed an agreement with Monitoring Services ESOES for LandRisk Logistics.Monitoring Services ESOES provide control centre assistance and bespoke route risk assessment for high value cargo owners. Hans Tino Hansen, CEO says:“It’s great to welcome Monitoring Services ESOES as a LandRisk Logistics client. We very much look forward to providing best in class intelligence via LandRisk Logistics, allowing ESOES to dynamically assess the risks faced over multiple lanes and rapidly adapt their route

Warrants of series TO1 were subscribed to approximately 98.6 percent and Wyld Networks AB receives approximately SEK 25.2 million

Wyld Networks AB (”Wyld Networks” or the ”Company”) today announces the outcome of the exercise of warrants of series TO1, which were issued in connection with the Company’s new issue in connection the listing on Nasdaq First North Growth Market (“Nasdaq First North”) in July 2021. In total, 2,243,999 warrants of series TO1 were exercised, corresponding to approximately 98.6 percent of the total number of outstanding warrants of series TO1, for subscription of 2,243,999 shares at a subscription price of SEK 11.25 per share. Wyld Networks will receive approximately SEK 25.2 million before

Audientes A/S nominates Frank Vium to join the Board of Directors.

Audientes A/S nominates Frank Vium to join the Board of Directors at the upcoming Annual General Meeting on April 21[st], 2022. The board’s competencies are further strengthened in the commercial field as well as in driving growth in technology-led companies.Audientes’ Board of Directors nominates Frank Vium to the Board of Directors at the Annual General Meeting on April 21[st], 2022. Frank Vium is a commercial executive with 25 years’ experience in driving growth and transformation in technology-led companies. Frank has held international leadership positions in Business Development,

Notice of Annual General Meeting 2022 in Audientes A/S

Notice of Annual General Meeting of Audientes A/S - Thursday, April 21[st] 2022 at 3 p.m. (15:00 CET)Notice of annual general meeting The Board of Directors of Audientes A/S, CVR No. 36 04 76 31, hereby convenes the Annual General Meeting of the Company, to be held: Thursday, April 21[st], 2022 at 3.00pm (15:00 CET) The annual general meeting will be held at the Company’s registered address atTeknikerbyen 5, 2., Søllerød, 2830 Virum. The agenda, including details of registration and power of attorney etc., can be found in the attached document. Registration Registration

ABS Supports Amver Awards Recognizing Norway’s Commitment to Saving Lives at Sea

(OSLO) ABS continued its long-standing support for the Amver Awards by sponsoring a ceremony recognizing the contribution of Norwegian shipping to the unique reporting system that supports search and rescue efforts for seafarers in distress. Hosted at the U.S. Ambassador’s Residence in Oslo, the ceremony saw 261 vessels from 40 Norwegian shipowners and operators honored for their commitment to maritime safety, making themselves available to assist in search and rescue activities anywhere in the world. “Safety at sea is a founding principle at ABS and nothing embodies it quite like the

Ingka Investments makes EUR 340 million investment in nine solar PV park projects in Europe as part of its commitment towards a renewable energy future

Ingka Investments, the investment arm of Ingka Group, acquires nine solar PV park projects in Germany and Spain from solar PV developer, ENERPARC. The total investment in the solar PV development portfolio will amount to approximately EUR 340 million.The expected energy capacity of the solar PV parks equals 300 megawatts in Germany across four solar PV development projects and 140 megawatts in Spain across five solar PV development projects. The expected production of the solar PV parks in Germany and Spain is equivalent to the electricity consumption of roughly 140,000 European households

Read original

Intervacc publishes the 2021 Annual Report

Stockholm, April 6, 2022 - Intervacc AB (publ) announces that the company's 2021 Annual Report has been published today. The annual report (in Swedish) is attached and an English unaudited translation of the report is available for download on the company's website www.intervacc.com . For more information please contact:   Andreas Andersson, CEO Phone:  +46-8-120 10 601, cell +46-73-335 99 70E-mail: andreas.andersson@intervacc.com The information was submitted for publication, through the agency of the contact person set out above on

Resqunit receives breakthrough initial order from Entreprises Shippagan Ltd worth SEK 9,4 million

Sandnes, Norway, April 6th, 2022 - Resqunit, ("RESQ") has received a Purchase Order totaling more than 30,000 units from Entreprises Shippagan Ltd in New Brunswick, Canada, who recently signed a distribution agreement for Resqunit products. "This order puts our company well ahead of our expected sales, where close to the entire 2022 budget is now in order backlog. After years of R&D efforts and raising awareness around ghost fishing and sustainability, this really is a groundbreaking market acceptance signal from the largest and most influential commercial fishery in the world", says

Katalysen Ventures AB (publ) publishes supplementary memorandum as a result of signed subscription commitments in ongoing listing issue

Katalysen Ventures AB (publ) ("Katalysen" or "the Company") hereby publishes a supplementary memorandum (the "Supplementary Memorandum") as a result of the Company’s 5 April 2022 announcement that Katalysen has signed subscription commitments during the current subscription period in the Company's listing issue. The supplementary memorandum is available on the Company's (www.katalysen.com), Spotlight Stock Market’s (www.spotlightstockmarket.com) and Nordic Issuing’s (www.nordic-issuing.se) websites respectively.The supplementary memorandum has been prepared in connection with Katalysen

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 89 - 6 APRIL 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 56/2022. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

Cereno Scientific publishes annual report for 2021

Cereno Scientific (XSAT: CRNO B) today announced that the annual report for 2021 is published on the company’s website, www.cerenoscientific.com.Cereno’s annual report for 2021 is available on the company’s website, both in Swedish and in English. The annual general meeting (AGM) will be held in Gothenburg, Sweden, on June 1, 2022. Notice and other documents related to the AGM will be available on the company's website no later than two weeks prior. For further information, please contact: Daniel Brodén, CFOPhone: +46 768 66 77 87Email: info@cerenoscientific.comhttp://www.

BioStock Studio: SynAct Pharma’s CEO on the rights issue and partnering discussions

Today, the subscription period begins in SynAct Pharma’s rights issue, which will primarily finance further clinical phase II development with AP1189 in rheumatoid arthritis. CEO Jeppe Øvlesen visited BioStock Studio to talk about why AP1189 stands out among other treatments for inflammatory and autoimmune diseases, and why the rights issue is being carried out at right now. We also get insights from SynAct Pharma’s discussions with potential partners and how they leverage the feedback they receive from these talks.Watch the interview with SynAct Pharma's CEO Jeppe Øvlesen at biostock.se:

There are no items matching the current filter
There are no more items matching the current filter
Back to top